Letter to the Editor Open Access
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 6, 2023; 11(7): 1666-1668
Published online Mar 6, 2023. doi: 10.12998/wjcc.v11.i7.1666
Commentary on a case report and literature review of acute carotid stent thrombosis
Matthew Willman, College of Medicine, University of Florida, Gainesville, FL 32610, United States
Brandon Lucke-Wold, Department of Neurosurgery, University of Florida, Gainesville, Florida 32608, United States
ORCID number: Matthew Willman (0000-0002-0388-2964); Brandon Lucke-Wold (0000-0001-6577-4080).
Author contributions: Willman M and Lucke-Wold B contributed to the conception and critical revision of the article; Willman M drafted the article.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Matthew Willman, BSc, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, United States. matthewwillman@ufl.edu
Received: November 4, 2022
Peer-review started: November 4, 2022
First decision: December 26, 2022
Revised: January 4, 2023
Accepted: February 15, 2023
Article in press: February 15, 2023
Published online: March 6, 2023
Processing time: 118 Days and 11.2 Hours

Abstract

In this commentary on the article entitled “Acute carotid stent thrombosis: A case report and literature review”, the key points of the article are discussed. Acute carotid stent thrombosis (ACST) in the setting of carotid artery stenting (CAS) represents a rare but potentially catastrophic event. There is a wide range of treatment options available, including carotid endarterectomy, which is generally recommended for cases of refractory ACST. While there is no standard treatment regimen, dual antiplatelet therapy is typically recommended both before and after CAS to reduce risk of ACST.

Key Words: Acute carotid stent thrombosis; Carotid artery stenting; Carotid endarterectomy

Core Tip: This commentary evaluates the article entitled “Acute carotid stent thrombosis: A case report and literature review”, discussing acute carotid stent thrombosis and the current treatment options available. Specifically, carotid endarterectomy is evaluated as a treatment option for refractory stent thrombosis. Additionally, dual antiplatelet therapy, stent material, and stent architectural design are addressed in the commentary.



TO THE EDITOR

Acute carotid stent thrombosis (ACST) is a rare (0.5%-5%) complication associated with significant risk in carotid artery stenting (CAS) as the study described[1-3]. Treatment options include thrombolysis, facilitated thrombolysis, percutaneous mechanical thrombectomy, thromboaspiration, and carotid endarterectomy (CEA), the procedure that was demonstrated in the case report of this paper.

Article findings and discussion

Zhang et al[3] outlined several risk factors that may be associated with ACST formation, including inadequate antiplatelet therapy and faulty positioning of the stent. In the subacute setting of carotid stent thrombosis, faulty positioning of the stent plays a more significant role in neointimal hyperplasia via vascular injury, which may ultimately cause restenosis after CAS[4].

The approach to ACST treatment is influenced by numerous factors. These factors include the presence of neurological injury, the timing ACST occurrence during stent placement or after the procedure, and the overall resources available to the treatment team. CEA is generally recommended in cases of refractory ACST and neurological deterioration[5]. While it has debatable benefit as a single criterion, carotid artery stump pressure measurement has been used to monitor cerebellar perfusion and potentially indicate the need for shunting during CEA[6]. In situations of asymptomatic ACST, the overall recommendation is to pursue conservative management without surgical intervention like CEA[5]. While there is limited data on the efficacy of dual antiplatelet therapy (DAPT) and no standard treatment dosing regimens are recommended, aspirin (75-325 mg) and clopidogrel (75 mg) DAPT daily are generally advised both before and after CAS for a minimum of four weeks post-procedure[7,8]. After discontinuation of DAPT, a daily aspirin lifelong regimen is advised. While there is increasing interest in the development of numerous stent materials, bare-metal carotid stents are currently the most commonly used[9].

The direction of future research and conclusion

At this time, there is limited data evaluating the use of drug-eluting carotid artery stents[9]. When comparing the open-cell to closed-cell architecture carotid stents, there is indication of lower rates of occlusions occurring in open-cell architecture carotid stents[10]. Research into the use of drug-eluting stents and stent architecture may offer therapeutic advantage for future treatment. Zhang et al[3] highlight the importance of predicting the potential risk of delayed treatment and the associated risk of ischemic brain injury. In the setting of an ACST, the balance between the benefit of CEA stroke reduction and the risks associated with surgical complications are difficult to predict in each patient situation. As Zhang et al[3] stated, the data is limited on the topic of ACST and further research into CEA as an intervention for ACST could prove beneficial.

Footnotes

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Medicine, research and experimental

Country/Territory of origin: United States

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B, B, B, B

Grade C (Good): 0

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Arunachalam J, India; Ding X, China; Sef D, United Kingdom S-Editor: Wang JJ L-Editor: A P-Editor: Wang JJ

References
1.  Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg. 1996;3:42-62.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Roubin GS, Yadav S, Iyer SS, Vitek J. Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am J Cardiol. 1996;78:8-12.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 204]  [Cited by in F6Publishing: 177]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
3.  Zhang JB, Fan XQ, Chen J, Liu P, Ye ZD. Acute carotid stent thrombosis: A case report and literature review. World J Clin Cases. 2022;10:9310-9317.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.5]  [Reference Citation Analysis (4)]
4.  Bonati LH, Gregson J, Dobson J, McCabe DJH, Nederkoorn PJ, van der Worp HB, de Borst GJ, Richards T, Cleveland T, Müller MD, Wolff T, Engelter ST, Lyrer PA, Brown MM; International Carotid Stenting Study investigators. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. Lancet Neurol. 2018;17:587-596.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 97]  [Cited by in F6Publishing: 94]  [Article Influence: 15.7]  [Reference Citation Analysis (0)]
5.  Coelho AP, Lobo M, Nogueira C, Gouveia R, Campos J, Augusto R, Coelho N, Semião AC, Canedo A. Overview of evidence on risk factors and early management of acute carotid stent thrombosis during the last two decades. J Vasc Surg. 2019;69:952-964.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 9]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
6.  Sef D, Skopljanac-Macina A, Milosevic M, Skrtic A, Vidjak V. Cerebral Neuromonitoring during Carotid Endarterectomy and Impact of Contralateral Internal Carotid Occlusion. J Stroke Cerebrovasc Dis. 2018;27:1395-1402.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 7]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
7.  Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;  American Stroke Assocation;  American Association of Neuroscience Nurses;  American Association of Neurological Surgeons;  American College of Radiology;  American Society of Neuroradiology;  Congress of Neurolgocial Surgeons;  Society of Atherosclerosis Imaging and Prevention;  Society for Cardiovascular Angiography and Interventions;  Society of Interventional Radiology;  Society of NeuroInterventional Surgery;  Society for Vascular Medicine;  Society for Vascular Surgery;  American Academy of Neurology and Society of Cardiovascular Computed Tomography. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke. 2011;42:e464-e540.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 89]  [Cited by in F6Publishing: 96]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
8.  Liapis CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes e Fernandes J, Biasi G, Norgren L; ESVS Guidelines Collaborators. ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg. 2009;37:1-19.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 441]  [Cited by in F6Publishing: 412]  [Article Influence: 27.5]  [Reference Citation Analysis (0)]
9.  He D, Liu W, Zhang T. The development of carotid stent material. Interv Neurol. 2015;3:67-77.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 15]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
10.  Müller MD, Gregson J, McCabe DJH, Nederkoorn PJ, van der Worp HB, de Borst GJ, Cleveland T, Wolff T, Engelter ST, Lyrer PA, Brown MM, Bonati LH. Stent Design, Restenosis and Recurrent Stroke After Carotid Artery Stenting in the International Carotid Stenting Study. Stroke. 2019;50:3013-3020.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 24]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]